Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report

[ad_1] Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD ) reported an increase in net income for the fourth quarter of 2022 when revenue rose 2%. Revenue increased by 2% annually to $7.4 billion in the last three months of fiscal…






